INTERNATIONAL PATENT: SAMSUNG BIOLOGICS CO., LTD., 삼성바이오로직스 주식회사 FILES APPLICATION FOR "NOVEL NUCLEIC ACID CONSTRUCT COMPRISING POLY(A) TAIL HAVING SECONDARY OR TERTIARY STRUCTURE AND CONTAINING NON-A SEQUENCE AT TERMINUS AND USES THEREOF"

GENEVA, May 5 -- SAMSUNG BIOLOGICS CO., LTD. (300, Songdo bio-daeroYeonsu-guIncheon 21987), 삼성바이오로직스 주식회사 (인천광역시연수구송도바이오대로 300) filed a patent application (PCT/KR2024/020402) for "NOVEL NUCLEIC ACID CONSTRUCT COMPRISING POLY(A) TAIL HAVING SECONDARY OR TERTIARY STRUCTURE AND CONTAINING NON-A SEQUENCE AT TERMINUS, AND USES THEREOF" on Dec 16, 2024. With publication no. WO/2026/089123, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC...